COMMUNIQUÉS West-GlobeNewswire

Janssen reports new head-to-head Phase 3 study data show ponesimod superiority versus Aubagio (teriflunomide) 14 mg in adults with relapsing multiple sclerosis
11/09/2019
• OPTIMUM Phase 3 study data presented for the first time during oral presentation at the 35th Congress of The European Committee for Treatment and Research in Multiple Sclerosis • Idorsia Pharmaceuticals Ltd, J&J [...]
PETVIVO HOLDINGS PROVIDES STAKEHOLDER UPDATE
11/09/2019
Minneapolis, MN, Sept. 11, 2019 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV ) Dear Stakeholders of PetVivo Holdings, Inc., PetVivo Holdings, Inc. (OTCQB: PETV) an emerging biomedical device company focused [...]
Beroni Group Launches its First-Ever Japan-Made Stem Cell Based Regenerative Skincare Products in the Rapidly Growing Chinese Consumer Market
11/09/2019
NEW YORK and SYDNEY, Australia, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Beroni Group Limited (NSX: BTG) (OTCQX: BNIGF) (“Company”) is pleased to announce that after five months of filing the registration, it has now secured [...]
T2 Biosystems Receives Funding from BARDA to Advance Technology for Diagnosis and Treatment of Bloodstream Infections
11/09/2019
LEXINGTON, Mass., Sept. 11, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in [...]
Richardson Healthcare Receives CE Mark Approval for its ALTA750®, Replacement Tube for Canon/Toshiba CXB-750D
11/09/2019
Available in Europe for Immediate Delivery LAFOX, Ill., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Richardson Healthcare , a Division of Richardson Electronics, Ltd. (NASDAQ: RELL), announced today it has received CE Mark [...]
Cerner Declares Quarterly Dividend
11/09/2019
KANSAS CITY, Mo., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Cerner (NASDAQ: CERN) announced its Board of Directors has declared a cash dividend to stockholders of $0.18 per issued and outstanding share. The cash dividend will [...]
Auris Medical Announces Notices of Allowance for U.S. and European Patent Applications Covering Intranasal Betahistine
11/09/2019
Received Notice of Allowance from United States Patent and Trademark Office -- Received “Intention to Grant” notice from European Patent Office Hamilton, Bermuda, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding [...]
Pro Mountain Biker Cam McCaul Partners with PlusCBD™ Oil
11/09/2019
SAN DIEGO, Sept. 11, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company,” “CV Sciences,” “our” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, is pleased to [...]
Marrone Bio Acquires Jet Ag and Jet Oxide Product Lines; Significantly Expands Opportunity in Agricultural Bioprotection Market
11/09/2019
New product lines provide immediate revenue growth and near-term earnings accretion DAVIS, Calif., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc . (NASDAQ: MBII), a leading developer of bio-based [...]
Pascal Biosciences to Present at International Cannabinoid Derived Pharmaceuticals Summit
11/09/2019
VANCOUVER, British Columbia and SEATTLE, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“ Pascal ” or the “ Company ”). Pascal announces that Dr. Patrick Gray, CEO, will present an update today [...]
Agritek Holdings, Inc. Announces Leadership Transition with Scott Benson as Company's New CEO
11/09/2019
Experienced Cannabis CEO to Focus on Growth, Profitability, and Communication LOS ANGELES, CA, Sept. 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Agritek Holdings, Inc. (OTC: AGTK) www.AgritekHoldings.com , a fully [...]
Arca Biopharma Announces Gencaro Atrial Fibrillation Clinical Data Selected for Presentation at HFSA 2019 Scientific Meeting
11/09/2019
WESTMINSTER, Colo., Sept. 11, 2019 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for [...]
Outlook Therapeutics to Present at the 29th Annual Ladenburg Thalmann 2019 Healthcare Conference
11/09/2019
CRANBURY, N.J., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK) (the “Company”) today announced that it is scheduled to participate in the Ladenburg Thalmann 2019 Healthcare Conference being [...]
Allena Pharmaceuticals to Host Key Opinion Leader Symposium on Unmet Need in Enteric Hyperoxaluria and Potential for Reloxaliase
11/09/2019
NEWTON, Mass., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics [...]
Intercept Launches NASHTRUTH.com, an Online Educational Resource for People with Advanced Fibrosis Due to NASH
11/09/2019
New NASH survey available on NASHTRUTH.com reveals that 6 out of 10 NASH patients say there is not enough information about the disease available to them NASHTRUTH.com provides people living with NASH with resources to [...]
Daré Bioscience Announces the Publication of a Pharmacokinetics Study of DARE-VVA1, a Novel Application of Tamoxifen for the Treatment of Vulvar and Vaginal Atrophy, in the International Journal of Pharmaceutics
11/09/2019
SAN DIEGO, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced the article entitled “Vaginal tamoxifen for treatment of vulvar and vaginal [...]
AroCell expands with a Regulatory Affairs Director
11/09/2019
AroCell AB (publ.) announces today that Peter Löwendahl joins the management team as senior director regulatory affairs. Peter Löwendahl will lead and develop AroCell’s regulatory strategy with focus on the US market [...]
ImmuCell Announces an Agreement Covering the Formulation and Aseptic Filling of Syringes for Re-Tain™
11/09/2019
PORTLAND, Maine, Sept. 11, 2019 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”) – a growing animal health company that develops, manufactures and markets scientifically-proven and [...]
BioRestorative Therapies Announces New Initiative to Target Polycystic Ovarian Syndrome
11/09/2019
MELVILLE, N.Y., Sept. 11, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that it has expanded its “off- [...]

Pages